Alpine Immune Sciences, Inc. announced that the Company presented the first clinical data of povetacicept in autoimmune glomerulonephritis during a late-breaking poster session at the American Society.
Palatin Initiates Enrollment in the Phase 2 Bremelanotide BREAKOUT Study in Patients with Diabetic Kidney Disease - read this article along with other careers information, tips and advice on BioSpace